Page last updated: 2024-10-28

fasudil and Eye Disorders

fasudil has been researched along with Eye Disorders in 1 studies

fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cheng, KJ1
Hsieh, CM1
Nepali, K1
Liou, JP1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison of the Postoperative Use of Dextenza (Dexamethasome Ophthalmic Insert) vs a Standard Regimen of Topical Fluorometholone After PRK[NCT05587231]Phase 460 participants (Anticipated)Interventional2022-10-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for fasudil and Eye Disorders

ArticleYear
Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye.
    Journal of medicinal chemistry, 2020, 10-08, Volume: 63, Issue:19

    Topics: Administration, Ophthalmic; Drug Delivery Systems; Drug Design; Eye Diseases; Genetic Therapy; Human

2020